CellCo — The Cell Company
HomePlatform
Programs
TherapeuticsCell-targeted siRNABiodefensePrevent · Protect · Secure
Team
Pipeline

Our Programs

One platform, two paths: medicines aimed at the cells that drive disease, and initiatives that keep essential medicines available when they are needed most.

01 · Therapeutics

Cell-targeted siRNA

Glycan ligands that route RNA medicines to the cells driving disease, starting with macrophages.

Explore→

02 · Biodefense

Biodefense Initiatives

Prevent infection. Protect vital organs. Secure essential medicines. Three initiatives spanning patient care and national preparedness.

Explore→
© 2026 Science AI Corporation (CellCo). All rights reserved.